Inventor
ULLMAN BRETT
US22 patents
⚠️ This page may combine multiple inventors who share the name “ULLMAN BRETT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
18 patentsUS9732039B2Aug 15, 2017
Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC17 citations91
US9126932B2Sep 8, 2015
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC17 citations91
US9522133B2Dec 20, 2016
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC9 citations83
US9012478B2Apr 21, 2015
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC4 citations83
US10479797B2Nov 19, 2019
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC9 citations82
US10058549B2Aug 28, 2018
Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC4 citations73
US11098034B2Aug 24, 2021
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations72
US10689372B2Jun 23, 2020
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations72
US10214518B2Feb 26, 2019
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC2 citations72
US9663500B2May 30, 2017
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC3 citations72
US11560386B2Jan 24, 2023
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC1 citations71
US10927123B2Feb 23, 2021
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC2 citations71
US10793529B2Oct 6, 2020
Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators
ARENA PHARM INC1 citations71
US10662200B2May 26, 2020
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC3 citations71
US11339172B2May 24, 2022
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto
ARENA PHARM INC3 citations70
US11987588B2May 21, 2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto
ARENA PHARM INC0 citations60
US10138210B2Nov 27, 2018
Substituted pyridazines as prostacyclin receptor modulators
ARENA PHARM INC1 citations60
US10351531B2Jul 16, 2019
Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
XIONG YIFENG
2 patentsUS9567327B2Feb 14, 2017
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
XIONG YIFENG57 citations96
US9434692B2Sep 6, 2016
Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
XIONG YIFENG18 citations90